Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05796648 · ClinicalTrials.gov registry record · NA

Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

A NA study of Obesity and Hypertension, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05796648 is a NA study of Obesity and Hypertension that has completed, run by University of Illinois at Chicago. The registered enrollment target is 18 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05796648, a NA study of Obesity and Hypertension, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention - grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.

Interventions

  • BEHAVIORAL RN-CHeFRx

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2023-06-01
Est. Completion 2024-02-15
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT05796648

The ClinicalTrials.gov registry entry for NCT05796648 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which RN-CHeFRx is the first listed.

NCT05796648 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05796648 about?

NCT05796648 is a clinical study titled "Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control". Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) inter...

What is the current status of trial NCT05796648?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-06-01. Estimated completion is 2024-02-15.

What conditions does trial NCT05796648 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Blood Pressure, Healthy Nutrition.

What interventions are being tested in trial NCT05796648?

The interventions under investigation include: RN-CHeFRx (BEHAVIORAL).

Who is sponsoring clinical trial NCT05796648?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05796648 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.